157 related articles for article (PubMed ID: 8014488)
1. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.
van Grunsven WM; Spaan WJ; Middeldorp JM
J Infect Dis; 1994 Jul; 170(1):13-9. PubMed ID: 8014488
[TBL] [Abstract][Full Text] [Related]
2. Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.
Fachiroh J; Stevens SJ; Haryana SM; Middeldorp JM
J Virol Methods; 2010 Oct; 169(1):79-86. PubMed ID: 20621126
[TBL] [Abstract][Full Text] [Related]
3. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
4. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
[TBL] [Abstract][Full Text] [Related]
5. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
6. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
7. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.
van Grunsven WM; van Heerde EC; de Haard HJ; Spaan WJ; Middeldorp JM
J Virol; 1993 Jul; 67(7):3908-16. PubMed ID: 7685403
[TBL] [Abstract][Full Text] [Related]
8. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
[TBL] [Abstract][Full Text] [Related]
9. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
[TBL] [Abstract][Full Text] [Related]
10. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
Xia C; Zhu K; Zheng G
Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888
[TBL] [Abstract][Full Text] [Related]
11. [IgA antibodies against Epstein-Barr virus capsid antigen].
Chalupa P; Slesinger P; Krchnáková A; Prásek J
Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
13. Inclusion bodies of recombinant Epstein-Barr virus capsid antigen p18 as potential immobilized antigens in enzyme immunoassays for detection of nasopharyngeal carcinoma.
Lim CS; Goh SL; Kariapper L; Krishnan G; Lim YY; Ng CC
Clin Chim Acta; 2015 Aug; 448():206-10. PubMed ID: 26164385
[TBL] [Abstract][Full Text] [Related]
14. Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay.
Cheng HM; Foong YT; Mathew A; Sam CK; Dillner J; Prasad U
J Virol Methods; 1993 Apr; 42(1):45-51. PubMed ID: 7686558
[TBL] [Abstract][Full Text] [Related]
15. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
[TBL] [Abstract][Full Text] [Related]
16. Serodiagnosis of infectious mononucleosis in children.
Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
Acta Paediatr Jpn; 1998 Aug; 40(4):328-32. PubMed ID: 9745774
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
de Ory F; Echevarría JM
Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
[TBL] [Abstract][Full Text] [Related]
18. Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay.
Shedd D; Angeloni A; Niederman J; Miller G
J Infect Dis; 1995 Nov; 172(5):1367-70. PubMed ID: 7594680
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
Puthavathana P; Kositanont U; Chongkolwatana C; Metheetrairut C; Chantarakul N; Nuntarakchaikul S; Wasi C
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557
[TBL] [Abstract][Full Text] [Related]
20. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
